FACULTY – Academy (All tentative, to be confirmed)

Rajiv Agarwal (Indianapolis, USA)

George Bakris (Chicago, USA)

Christie Ballantyne (Houston, USA)

Stefan Blankenberg (Hamburg, GER)

Lucas Boersma (Antwerp, BEL)

Robert Bonow (Chicago, USA)

Jeffrey Borer (New York, USA)

Mike Bristow (Aurora and Boulder, USA)

John Buse (Chapel Hill, USA)

Javed Butler (New York, USA)

John Camm (London, GBR)

John Cleland (Glasgow, GBR)

Stuart Connoly (Hamilton, CAN)

Martin Cowie (London, GBR)

William Cushman (Memphis, USA)

Holli DeVon (Chicago, USA)

Frederick E Dewey (Tarrytown, USA)

John Eikelboon (Austin, USA)

Nir Eyal (Boston, USA)

Michael Felker (Durham, USA)

Mona Fiuzat (FDA/Duke, USA)

Philippe Générieux (New York, USA)

Michael Gibson (Boston, USA)

Nicolas Girerd (Nancy, FRA)

Robert Harrington (Stanford York, USA)

Adrian Hernandez (Durham, USA)

Ziad Hijazi, (Uppsala, SWE)

Martin Holtzman (Huddinge, SWE)

Jim Januzzi (Boston, USA)

Paulus Kircchof (Münster, GER)

Sander Kersten (Wageningen, NED)

Lars Kober (Copenhague, DEN)

Carolyn Lam (Singapore, SGP)

Martin Leon (New York, USA)

Gregory Lewis (Boston, USA)

Peter Libby (Boston, USA)

Cecilia Linde (Stockholm, SWE)

Gregory Lip (Birmingham, GBR)

Rajendra Makkar (Los Angeles, USA)

Steve Marso (Dallas, USA)

Darren McGuire (Dallas, USA)

John McMurray (Glasgow, GBR)

Alexandre Mebazaa (Paris, FRA)

Roxana Mehran (New York, USA)

Nick Mills (Edinburgh,GBR)

Javid Moslehi (Nashville, USA)

Marie Claude Morice (Massy, FRA)

Karl Moons (Utrecht, NED)

Matthias Nahrendorf (Boston, USA)

Bruce Neal (Sydney, AUS)

Stephen Nicholls (Adelaide, AUS)

Chris O'Connor (Inova, USA)

Douglas Packer (Rochester, USA)

Milton Packer (Dallas, USA)

Peter Pang (Chicago, USA)

Vlado Perkovic (Sydney, AUS)

Marc Pfeffer (Boston, USA)

Burkert Pieske (Berlin, GER)

Bertram Pitt (Ann Arbor, USA)

Stuart Pocock (London, GBR)

Aruna Pradhan (Boston USA)

Kausik Ray (London GBR)

Matthew Reynolds (Boston, USA)

Paul Ridker (Boston, USA)

Matthew Roe (Durham, USA)

Claudio Ronco (Vicenza, ITA)

Patrick Rossignol (Nancy, FRA)

Marc Sabatine (Boston, USA)

Philip Sager (Stanford, USA)

Nabil Seidah (Montreal, CAN)

Naveed Sattar (Glasgow, GBR)

Leslie Saxon (Los Angeles, USA)

Heribert Schunkert (Munich, GER)

John Spertus (Kansas City, USA)

Steven Steinhubl (La Jolla, USA)

Gabriel Steg (Paris, FRA)

Gregg W. Stone (Columbus, USA)

Scott Solomon (Boston, USA)

Ira Tabas (New York, USA)

Jean Claude Tardif (Montreal, CAN)

Alexander Tenenbaum (Tel Aviv, ISR)

John Teerlink (San Francisco, USA)

Martin Than (London, GBR)

Sotirios Tsimikas (Carlsbad, USA)

Eric Topol (La Jolla, USA)

Mintu Turakhia (Stanford, USA)

Marco Valgimigli (Bern, CHE)

Eric Velasquez (Durham, USA)

Adrian Voors (Groningen, NED)

Christoph Wanner (Würzburg, GER)

Dave Whellan (Durham, USA)

John Wilbanks (Sage BioNetworks, USA)

Stephan Windecker (Bern, CHE)

Janet Wittes (Statistics Collaborative, USA)

Bernie Zinman (Toronto, CAN)


 

FACULTY – Industry (All tentative, to be confirmed)

Philip Adamson (Abbott, USA)

Corine Bernaud (Idorsia, CHE)

Agim Beshiri (Abbott, USA)

Elisabeth Björk (AstraZeneca, SWE)

Dan Bloomfield (Merck, USA)

Robin Bostic (Abbott, USA)

John Brennan (MedTech Europe, BEL)

Jim Carr (Stealth Peptide, USA)

Richard Clark (Medtronic, USA)

Mehul Desai (AstraZeneca, USA)

George Dangas (Bayer, GER)

Kourtney Davis (GSK, USA)

Ngozi Erondu (Janssen, USA)

Gary Gintant (AbbVie, USA)

Claudio Gimpelewicz (Novartis, CHE)

Gerald Heatley (St Jude, USA)

Johannes Holzmeister (Cardirentis, CHE)

Paul Julicher (Abbott, USA)

David Kallend (The Medicine Company, USA)

Helina Kassahun (Amgen, USA)

Jeorg Koglin (Merck, USA)

Marty Lefkowitz (Novartis, USA)

Craig Lipset (Pfizer, USA)

Michael McConnell (Verily Life Sciences, USA)

Joerg Moeller (Bayer, GER)

Alan Charles Moses (Novo Nordisk, DEN)

Gillian Murtagh (Abbott, USA)

Ameet Nathwani (Sanofi, FRA)

Norman Rosenthal (Janssen, USA)

Kyu Rhee (IBM, USA)

Mahesh Patel (Merck, USA)

Robert Scott (Amgen, USA)

Shalabh Singhal (BMS, USA)

Monica Shah (Quintiles, USA)

Kenneth Stein (Boston Scientific, USA)

Poornima Sood (St Jude, USA)

Julia Stubben (Medtech Europe, CH)

Tom Thuren (Novartis, CH)

Richard Thomas (Quintiles, USA)

Rick Turner (Quintiles, USA)

Martin Unverdorben (Daiichi Sankyo, USA)

Yves Verboven (MedTech Europe, BEL)

Jeff Williams (Apple, USA)

Hans Juergen Woerle (Boehringer Ingelheim, GER)

Nadim Yared (Advamed, CVRx, USA)

 

FACULTY – Payers (All tentative, to be confirmed)

Naomi Aaronson (Blue Cross, USA)

Cristina Akerman (ICHOM, Boston, USA)

Suzanne Belinson (Evidence Street, BCBS, USA)

Meindert Boysen (NICE, GBR)

Joseph Chin (CMS, USA)

Aileen Clarkea (Warwick, GBR)

Dennis Irwin, (Optum, United Health Care, USA)

Stephen Gorshow  (UnitedHealthcare, USA)

Liz Paxton (Kaiser Permanente, USA)

Tamara Syrek Jensen (CMS, USA)


 

FACULTY - Patients (All tentative, to be confirmed)
Cynthia Chauhan (Wichita, USA)

Bray Patrick-Lake (Durham, USA)

Sharon Terry (Washington DC, USA)

 

Journal editors (All tentative, to be confirmed)

John Jarcho (NEJM, Boston, USA)

Stuart Spencer (The Lancet, London, GBR)

 

FACULTY - Regulatory – Government Agencies (All tentative, to be confirmed)

Fernando Aguel (FDA, USA)

Angeles Alonso (EMA, GBR)

Timothy Baldwin (NHLBI, USA)

Christina Dunder (EMA, SWE)

Joseph Emmerich (EMA, Paris, FRA)

Steve Fearn (FDA, USA)

Nancy Geller (NHLBI, USA)

Jean Marc Guettier (FDA, USA)

Karen Hicks (FDA, USA)

John Laschinger (FDA,USA)

Michael Lauer (NIH, USA)

Neil McGuire (MHRA, GBR)

Bakul Patel  (FDA, USA)

Gail Pearson (FDA, USA)

Krishna Prasad (EMA, GBR)

Linda Ricci (FDA, USA)

Kaori Shinagawa (PMDA, JPN)

Jim Smith (FDA, USA)

Norman Stockbridge (FDA, USA)

Robert Temple (FDA, USA)

Aliza Thompson (FDA, USA)

Christian Thuilliez (CNEDIMS, HAS, FRA)

Ullis Unger (FDA, USA)

Bart Van der Schueren (EMA, BEL)

Bernard Vasseur (FDA, USA)

John Whyte (FDA, USA)

Bram Zuckerman (FDA, USA)